Nature Reviews Clinical Oncology, volume 7, issue 12, pages 702-707

BRCA mutations in the management of breast cancer: the state of the art

Narod Steven A. 1
1
 
Womens College Research Institute, Toronto, Canada
Publication typeJournal Article
Publication date2010-10-19
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor78.8
ISSN17594774, 17594782
Oncology
Abstract
Genetic testing for BRCA1 and BRCA2 mutations is gaining acceptance in clinical oncology worldwide and may help target unaffected high-risk women for prevention and for close surveillance. Annual screening with MRI seems to be an effective surveillance strategy, but the long term follow-up of women with small MRI-detected breast cancers is necessary to establish its ultimate value. Women with cancer and a BRCA mutation may benefit from tailored treatments, such as cisplatin or olaparib. The treatment goals for a woman with a BRCA-associated breast cancer should be to prevent recurrence of the initial cancer and to prevent second primary breast and ovarian cancers. Mutations in BRCA1 and BRCA2 are presented throughout the world and it is important that the benefits of genetic testing and of targeted therapies be extended to women who live outside of North America and Western Europe.

Citations by journals

2
4
6
8
10
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 10, 8.2%
Breast Cancer Research and Treatment
10 publications, 8.2%
Oncotarget
Oncotarget, 3, 2.46%
Oncotarget
3 publications, 2.46%
Cancer Causes and Control
Cancer Causes and Control, 3, 2.46%
Cancer Causes and Control
3 publications, 2.46%
BMC Cancer
BMC Cancer, 3, 2.46%
BMC Cancer
3 publications, 2.46%
Future Oncology
Future Oncology, 2, 1.64%
Future Oncology
2 publications, 1.64%
Current Opinion in Obstetrics and Gynecology
Current Opinion in Obstetrics and Gynecology, 2, 1.64%
Current Opinion in Obstetrics and Gynecology
2 publications, 1.64%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 1.64%
International Journal of Molecular Sciences
2 publications, 1.64%
Frontiers in Endocrinology
Frontiers in Endocrinology, 2, 1.64%
Frontiers in Endocrinology
2 publications, 1.64%
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, 2, 1.64%
Hereditary Cancer in Clinical Practice
2 publications, 1.64%
Hematology/Oncology Clinics of North America
Hematology/Oncology Clinics of North America, 2, 1.64%
Hematology/Oncology Clinics of North America
2 publications, 1.64%
Cancer
Cancer, 2, 1.64%
Cancer
2 publications, 1.64%
International Journal of Cancer
International Journal of Cancer, 2, 1.64%
International Journal of Cancer
2 publications, 1.64%
ACS Chemical Biology
ACS Chemical Biology, 2, 1.64%
ACS Chemical Biology
2 publications, 1.64%
Journal of Breast Cancer, 2, 1.64%
Journal of Breast Cancer
2 publications, 1.64%
Biotekhnologiya, 1, 0.82%
Biotekhnologiya
1 publication, 0.82%
Applied Biochemistry and Microbiology
Applied Biochemistry and Microbiology, 1, 0.82%
Applied Biochemistry and Microbiology
1 publication, 0.82%
Pharmacological Reviews
Pharmacological Reviews, 1, 0.82%
Pharmacological Reviews
1 publication, 0.82%
Journal of Clinical Investigation
Journal of Clinical Investigation, 1, 0.82%
Journal of Clinical Investigation
1 publication, 0.82%
Endocrine-Related Cancer
Endocrine-Related Cancer, 1, 0.82%
Endocrine-Related Cancer
1 publication, 0.82%
Personalized Medicine
Personalized Medicine, 1, 0.82%
Personalized Medicine
1 publication, 0.82%
Lifestyle Genomics
Lifestyle Genomics, 1, 0.82%
Lifestyle Genomics
1 publication, 0.82%
Medical Principles and Practice
Medical Principles and Practice, 1, 0.82%
Medical Principles and Practice
1 publication, 0.82%
Journal of Clinical Medicine
Journal of Clinical Medicine, 1, 0.82%
Journal of Clinical Medicine
1 publication, 0.82%
Oncology Letters
Oncology Letters, 1, 0.82%
Oncology Letters
1 publication, 0.82%
International Journal of Molecular Medicine
International Journal of Molecular Medicine, 1, 0.82%
International Journal of Molecular Medicine
1 publication, 0.82%
Oncology Reports
Oncology Reports, 1, 0.82%
Oncology Reports
1 publication, 0.82%
Obstetrics and Gynecology
Obstetrics and Gynecology, 1, 0.82%
Obstetrics and Gynecology
1 publication, 0.82%
Current Opinion in Oncology
Current Opinion in Oncology, 1, 0.82%
Current Opinion in Oncology
1 publication, 0.82%
Breast Cancer: Basic and Clinical Research
Breast Cancer: Basic and Clinical Research, 1, 0.82%
Breast Cancer: Basic and Clinical Research
1 publication, 0.82%
2
4
6
8
10

Citations by publishers

5
10
15
20
25
30
35
Springer Nature
Springer Nature, 33, 27.05%
Springer Nature
33 publications, 27.05%
Elsevier
Elsevier, 19, 15.57%
Elsevier
19 publications, 15.57%
Wiley
Wiley, 7, 5.74%
Wiley
7 publications, 5.74%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 5, 4.1%
Multidisciplinary Digital Publishing Institute (MDPI)
5 publications, 4.1%
Wolters Kluwer Health
Wolters Kluwer Health, 4, 3.28%
Wolters Kluwer Health
4 publications, 3.28%
Future Medicine
Future Medicine, 3, 2.46%
Future Medicine
3 publications, 2.46%
Impact Journals
Impact Journals, 3, 2.46%
Impact Journals
3 publications, 2.46%
Spandidos Publications
Spandidos Publications, 3, 2.46%
Spandidos Publications
3 publications, 2.46%
SAGE
SAGE, 3, 2.46%
SAGE
3 publications, 2.46%
Oxford University Press
Oxford University Press, 3, 2.46%
Oxford University Press
3 publications, 2.46%
S. Karger AG
S. Karger AG, 2, 1.64%
S. Karger AG
2 publications, 1.64%
Frontiers Media S.A.
Frontiers Media S.A., 2, 1.64%
Frontiers Media S.A.
2 publications, 1.64%
American Chemical Society (ACS)
American Chemical Society (ACS), 2, 1.64%
American Chemical Society (ACS)
2 publications, 1.64%
Taylor & Francis
Taylor & Francis, 2, 1.64%
Taylor & Francis
2 publications, 1.64%
Korean Breast Cancer Society, 2, 1.64%
Korean Breast Cancer Society
2 publications, 1.64%
Hindawi Limited
Hindawi Limited, 2, 1.64%
Hindawi Limited
2 publications, 1.64%
State Research Institute for Genetics and Selection of Industrial Microorganisms, 1, 0.82%
State Research Institute for Genetics and Selection of Industrial Microorganisms
1 publication, 0.82%
Pleiades Publishing
Pleiades Publishing, 1, 0.82%
Pleiades Publishing
1 publication, 0.82%
American Society for Pharmacology and Experimental Therapeutics
American Society for Pharmacology and Experimental Therapeutics, 1, 0.82%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.82%
American Society for Clinical Investigation
American Society for Clinical Investigation, 1, 0.82%
American Society for Clinical Investigation
1 publication, 0.82%
Bioscientifica
Bioscientifica, 1, 0.82%
Bioscientifica
1 publication, 0.82%
Moffitt Cancer Center
Moffitt Cancer Center, 1, 0.82%
Moffitt Cancer Center
1 publication, 0.82%
KeAi Communications Co.
KeAi Communications Co., 1, 0.82%
KeAi Communications Co.
1 publication, 0.82%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 0.82%
Public Library of Science (PLoS)
1 publication, 0.82%
American Society for Nutrition
American Society for Nutrition, 1, 0.82%
American Society for Nutrition
1 publication, 0.82%
Asian Pacific Organization for Cancer Prevention, 1, 0.82%
Asian Pacific Organization for Cancer Prevention
1 publication, 0.82%
American Association for Clinical Chemistry
American Association for Clinical Chemistry, 1, 0.82%
American Association for Clinical Chemistry
1 publication, 0.82%
Society for Translational Oncology
Society for Translational Oncology, 1, 0.82%
Society for Translational Oncology
1 publication, 0.82%
BMJ
BMJ, 1, 0.82%
BMJ
1 publication, 0.82%
5
10
15
20
25
30
35
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Narod S. A. BRCA mutations in the management of breast cancer: the state of the art // Nature Reviews Clinical Oncology. 2010. Vol. 7. No. 12. pp. 702-707.
GOST all authors (up to 50) Copy
Narod S. A. BRCA mutations in the management of breast cancer: the state of the art // Nature Reviews Clinical Oncology. 2010. Vol. 7. No. 12. pp. 702-707.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/nrclinonc.2010.166
UR - https://doi.org/10.1038%2Fnrclinonc.2010.166
TI - BRCA mutations in the management of breast cancer: the state of the art
T2 - Nature Reviews Clinical Oncology
AU - Narod, Steven A.
PY - 2010
DA - 2010/10/19 00:00:00
PB - Springer Nature
SP - 702-707
IS - 12
VL - 7
SN - 1759-4774
SN - 1759-4782
ER -
BibTex |
Cite this
BibTex Copy
@article{2010_Narod,
author = {Steven A. Narod},
title = {BRCA mutations in the management of breast cancer: the state of the art},
journal = {Nature Reviews Clinical Oncology},
year = {2010},
volume = {7},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1038%2Fnrclinonc.2010.166},
number = {12},
pages = {702--707},
doi = {10.1038/nrclinonc.2010.166}
}
MLA
Cite this
MLA Copy
Narod, Steven A.. “BRCA mutations in the management of breast cancer: the state of the art.” Nature Reviews Clinical Oncology, vol. 7, no. 12, Oct. 2010, pp. 702-707. https://doi.org/10.1038%2Fnrclinonc.2010.166.
Found error?